Upload Avatar (500 x 500)
Bin Jiang
Pharmaceutical Sciences
Peking University
Beijing
Language: Chinese, English
Pharmaceutical Policy
Decision-Making
Effect Evaluation
Healthcare Reform
Pharmaceutical Industry
Development
Government
Regulatory Capacity
Building
Evaluation
Areas of Focus
- Pharmaceutical Policy Decision-Making and Effect Evaluation
- New Healthcare Reform and Pharmaceutical Industry Development
- Government Regulatory Capacity Building and Evaluation
Work Experience
- 2021.05-Present - Peking University Health Science Center, Executive Deputy Director of the Medical Technology Development and Research Center
- 2018.06-Present - Peking University Public Policy Research Center, Deputy Director and Researcher
- 2010.09-2012.02 - Harvard Medical School, Senior Visiting Scholar and Postdoctoral Fellow
- 2000.03-Present - Peking University School of Pharmaceutical Sciences, Lecturer and Associate Professor
- 1997.07-2000.02 - Beijing Medical University School of Pharmaceutical Sciences, Teaching Assistant and Lecturer
Academic Background & Achievements
- PhD in Management: Renmin University of China
- Master's in Economics: Renmin University of China
- Bachelor's in Science: Beijing Normal University
Publications
- Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus, Jing Yuan, Z. Kevin Lu, Xiaomo Xiong, Tai-Ying Lee, Huang Huang and Bin Jiang, 2022
- The impact of the reference pricing policy in China on drug procurement and cost, Bin Jiang, Ruo Jing Zhou, Xing Lin Feng, 2022
- Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China, Jing Yuan, Z Kevin Lu, Xiaomo Xiong, Bin Jiang, 2021
- Does pre-operative halo-gravity traction reduce the degree of deformity and improve pulmonary function in severe scoliosis patients with pulmonary insufficiency? A systematic review and meta-analysis, Zhao Yang, Yang Liu, Longtao Qi, Shanshan Wu, Jingwen Li, Yu Wang, Bin Jiang, 2021
- Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis, Lu ZK, Xiong X, Lee T, Wu J, Yuan J, Jiang B, 2021
- Mobile Apps for Drug–Drug Interaction Checks in Chinese App Stores: Systematic Review and Content Analysis, Chunying Shen, Bin Jiang, Qilian Yang, Chengnan Wang, Kevin Z Lu, 2021
- Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management, Xiaomo Xiong, Jing Yuan, Minghui Li, Bin Jiang, Kevin Lu, 2021
- Physicians’ Knowledge, Altitudes, and Perceived Barriers of Inappropriate Prescribing for Older Patients in Shanghai, China, Jing Yuan, Guizhi Yin, Meng Gu, Kevin Z. Lu, Bin Jiang and Minghui Li, 2022
- Impact of financial barriers on health status, healthcare utilization and economic burden among individuals with cognitive impairment: a national cross-sectional survey, Lu ZK, Xiong X, Horras A., Jiang B. M Li, 2022
- 国家组织药品带量采购政策的控费效果及其影响因素研究, 周若婧，江滨, 2022
- The effects of the national drug pooled procurement (NDPP) pilot program in China, Ningtai Luo, Jianying Yue, Ruojing Zhou, Bin Jiang, 2022
- 准公共产品视域下的城乡居民基本医保服务地区间均等性评价, 周若婧, 黄璜, 江滨, 2022
